Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNYSE:ACT
Date10/2013
Raised
Post IPO Valuation

General Information

Websiteactavis.com
CategoryBioTech
Phone1 (862) 261-7488
Employees10,000
Founded1984
Descriptionpharmaceutical company

Offices

Parsippany, USA
400 Interpace Parkway
Parsippany, NJ, 07054
USA

People

CFO
President
President, Actavis Global R&D
President, Global Operations
Chairman and Chief Executive Officer
Chief Legal Officer
Chief Human Resources Officer
Chief Communications Officer

Acquisitions

Total$33.6B
Silommedical, 4/2014 $100M
Forest Laboratories, 2/2014 $25B
Warner Chilcott, 5/2013 $8.5B

Tags

Actavis

Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.

The Company has global headquarters in Dublin, Ireland and Administrative Headquarters in Parsippany, New Jersey, USA.

Recent Milestones

Videos

Screenshots

Actavis screenshot
Above: screenshots
Uploaded: 4/8/14

Stock Price

Sources

  1. Actavis Acquires Silom Medical Company (finance.yahoo.com) [edit]
  2. Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction (ir.actavis.com) [edit]
  3. Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company (ir.actavis.com) [edit]
  4. Actavis Said to Near $25 Billion Deal to Buy Forest Laboratories (bloomberg.com) [edit]
Edit This Page
Last Edited 4/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy